Drugs to Treat Bone Metastases

Some men diagnosed with prostate cancer will have their cancer spread (metastasize) to other parts of the body. The bones are a common place for cancer to spread.

Two classes of drugs used to treat cancer that has spread to the bone are:
  1. Bisphosphonates: prevent loss of bone mass
  2. Denosumab: block osteoclasts (bone cells) from breaking down bone

Everyone responds to therapies for treating bone metastases differently. Talk to your doctor or pharmacist about what to expect, including any side-effects you may experience while on these medications. Some therapies used to treat prostate cancer may interact with other prescription or non-prescription medications you are taking. Tell your doctor or pharmacist if you are taking any medications.

Below are common drugs used to treat bone metastases. Click on each drug name for further information including:
  • what the drug is and how it works
  • how the drug is administered
  • possible side effects of the drug
  • whether the drug is covered by your provincial drug program

Alendronate (Fosamax®)

Denosumab (Xgeva®)

Pamidronate (Aredia®)

Zoledronic Acid (Zometa®) 

Last Reviewed: July 2017




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Université de Sherbrooke Researchers’ Findings Published in Cancer Research

Sherbrooke, November 16, 2017 – Prostate cancer, the most common cancer in men, affects one out of seven Canadian men.
More

12 innovative Canadian prostate cancer researchers set out to make new Discoveries

Toronto, ON – September 28, 2017: 12 forward-thinking Canadian prostate cancer researchers have been rewarded for their innovation with Movember Discovery Grants.
More

Gray Tools '2017 Together We Are Stronger' campaign a success in creating awareness and raising funds for prostate cancer

BRAMPTON, Ontario, Sept 26, 2017 (GLOBE NEWSWIRE) -- Gray Tools Canada Inc, in cooperation with Prostate Cancer Canada, is proud to announce that its “2017 Together We Are Stronger” initiative raised $4,000, which will go directly towards funding valuable research that is needed to improve the way we diagnose, treat, and support men living with the disease.
More


Click here for news archive